Managing ITP in dogs — an autoimmune destruction of platelets causing life-threatening bleeding risk.
Immune-mediated thrombocytopenia causes significant welfare impairment through the risk and reality of haemorrhage. Dogs with severe thrombocytopenia are at constant risk of spontaneous bleeding from any site — the petechiae and bruising visible on skin are markers of this systemic bleeding tendency. Internal haemorrhage causes anaemia, weakness, and organ compromise. Intracranial haemorrhage is catastrophic.
The welfare of acute ITP management involves intensive hospitalisation, blood product transfusion, and immunosuppressive therapy initiation. The monitoring for signs of internal haemorrhage — deteriorating mentation, sudden collapse, rapid anaemia — is continuous. Owners and veterinarians must balance treatment with welfare assessment throughout.
Response to immunosuppressive therapy is usually positive but takes days to weeks. During this period, extreme caution is required — no intramuscular injections, minimal venipuncture, and padded housing to prevent trauma. Most dogs with primary ITP achieve remission; some require long-term low-dose immunosuppression to prevent relapse.